TLSI logo

TLSI TriSalus Life Sciences, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$2.36
-0.09 (-3.49%)

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion S…

Market Cap: $145.89Mtrisaluslifesci.com

Price

No data yet.

Social Signal Score

53
5d
—
30d
60
3 mentions
—
60d
58
4 mentions
—
90d
42
6 mentions
—
news: 6

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$10+322.9%
Low $4Median $12High $12
Current Consensus

Revenue

$12.88M
$0.00$4.40M$8.80M$13.21M
Dec 2020Sep 2026

Analyst Estimates

FY2025
$-1.76
$-1.86–$-1.68
3 analysts
FY2026
$-0.43
$-0.46–$-0.41
3 analysts
FY2027
$-0.53
$-0.56–$-0.50
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Mary T. Szela
Sector
Healthcare
Industry
Medical - Devices
Employees
102
Beta
0.51
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-6.41
trisaluslifesci.com